PHIO icon

Phio Pharmaceuticals

13 hedge funds and large institutions have $551K invested in Phio Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
7
Closed
5
Calls
$37K
Puts
Net Calls
+$37K
Net Calls Change
+$37K
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$210K 297,971 -6,148 -2%
Renaissance Technologies
2
Renaissance Technologies
New York
$165K 234,849 +193,349 +466%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$77K 107,192
Cetera Investment Advisers
4
Cetera Investment Advisers
Illinois
$53K 75,000 -15,000 -17%
Two Sigma Investments
5
Two Sigma Investments
New York
$20K 27,793 +27,793 New
VF
6
Virtu Financial
New York
$11K 15,371 -27,316 -64%
TSS
7
Two Sigma Securities
New York
$7K 10,307 -12,868 -56%
TRCT
8
Tower Research Capital (TRC)
New York
$6K 8,183 +8,183 New
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$1K 870 -627 -42%
Morgan Stanley
10
Morgan Stanley
New York
$1K 1,500 -7 -0.5%
Two Sigma Advisers
11
Two Sigma Advisers
New York
-46,700 Closed
BlackRock
12
BlackRock
New York
$0 19 -34,825 -100%
Millennium Management
13
Millennium Management
New York
-10,241 Closed
UBS Group
14
UBS Group
Switzerland
-2,685 Closed
Citigroup
15
Citigroup
New York
-1,000 Closed
Group One Trading
16
Group One Trading
Illinois
-300 Closed
FIA
17
FNY Investment Advisers
New York
CFGS
18
Concourse Financial Group Securities
Alabama
Wells Fargo
19
Wells Fargo
California
$0 59 +6 +11%
Simplex Trading
20
Simplex Trading
Illinois
$0 398 +398 New